Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa M Ledet

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 10, 2021
Changes in taste and smell of food during prostate cancer treatmentSarah Alonzi, Michael Hoerger, Laura M Perry, et al.
Clinical Genitourinary Cancer|September 22, 2016
Radium-223 Use in Clinical Practice and Variables Associated With Completion of TherapyRana R McKay, Susanna Jacobus, Matthew Fiorillo, et al.
Clinical Genitourinary Cancer|November 14, 2022
Clinical and Genetic Analysis of Metastatic Prostate Cancer to the Central Nervous System: A Single-Institution Retrospective ExperienceAlbert Jang, Ellen B Jaeger, Elisa M Ledet, et al.
The Prostate|March 24, 2021
Family history and pathogenic/likely pathogenic germline variants in prostate cancer patientsRachel A Sabol, Elisa M Ledet, Ellen Jaeger, et al.
The Oncologist|April 17, 2020
Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate CancerElisa M Ledet, Michael B Lilly, Guru Sonpavde, et al.
Clinical Genitourinary Cancer|December 12, 2019
TP53 Gain-of-Function Mutations in Circulating Tumor DNA in Men With Metastatic Castration-Resistant Prostate CancerLynne Chapman, Elisa M Ledet, Pedro C Barata, et al.
Molecular Cancer Research : MCR|July 11, 2022
A Recurrent ADPRHL1 Germline Mutation Activates PARP1 and Confers Prostate Cancer Risk in African American FamiliesGuanyi Zhang, Zemin Wang, Jasmin Bavarva, et al.
The Prostate|March 24, 2023
Clinical and molecular determinants of PSA response to bipolar androgen therapy in prostate cancerSydney A Caputo, Madeline Hawkins, Ellen B Jaeger, et al.
Cancer|January 9, 2019
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancerGuru Sonpavde, Neeraj Agarwal, Gregory Russell Pond, et al.
The Prostate|April 28, 2023
Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamideAlbert Jang, Sree M Lanka, Minqi Huang, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 10, 2021
Changes in taste and smell of food during prostate cancer treatmentSarah Alonzi, Michael Hoerger, Laura M Perry, et al.
Clinical Genitourinary Cancer|September 22, 2016
Radium-223 Use in Clinical Practice and Variables Associated With Completion of TherapyRana R McKay, Susanna Jacobus, Matthew Fiorillo, et al.
Clinical Genitourinary Cancer|November 14, 2022
Clinical and Genetic Analysis of Metastatic Prostate Cancer to the Central Nervous System: A Single-Institution Retrospective ExperienceAlbert Jang, Ellen B Jaeger, Elisa M Ledet, et al.
The Prostate|March 24, 2021
Family history and pathogenic/likely pathogenic germline variants in prostate cancer patientsRachel A Sabol, Elisa M Ledet, Ellen Jaeger, et al.
The Oncologist|April 17, 2020
Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate CancerElisa M Ledet, Michael B Lilly, Guru Sonpavde, et al.
Clinical Genitourinary Cancer|December 12, 2019
TP53 Gain-of-Function Mutations in Circulating Tumor DNA in Men With Metastatic Castration-Resistant Prostate CancerLynne Chapman, Elisa M Ledet, Pedro C Barata, et al.
Molecular Cancer Research : MCR|July 11, 2022
A Recurrent ADPRHL1 Germline Mutation Activates PARP1 and Confers Prostate Cancer Risk in African American FamiliesGuanyi Zhang, Zemin Wang, Jasmin Bavarva, et al.
The Prostate|March 24, 2023
Clinical and molecular determinants of PSA response to bipolar androgen therapy in prostate cancerSydney A Caputo, Madeline Hawkins, Ellen B Jaeger, et al.
Cancer|January 9, 2019
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancerGuru Sonpavde, Neeraj Agarwal, Gregory Russell Pond, et al.
The Prostate|April 28, 2023
Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamideAlbert Jang, Sree M Lanka, Minqi Huang, et al.
Pageof 3